Skip to main navigation Skip to search Skip to main content

A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement

  • Mengmeng Jiang
  • , Zhuozhao Zheng
  • , Xuan Wang
  • , Yanhao Chen
  • , Jing Qu*
  • , Qiurong Ding*
  • , Weiqi Zhang*
  • , You Shuo Liu*
  • , Jichun Yang*
  • , Weiqing Tang*
  • , Yunlong Hou*
  • , Jinhan He*
  • , Lin Wang*
  • , Pengyu Huang*
  • , Lin Chen Li*
  • , Zhiying He*
  • , Qiang Gao*
  • , Qian Lu*
  • , Lai Wei*
  • , Yan Jiang Wang*
  • Zhenyu Ju*, Jian Gao Fan*, Xiong Zhong Ruan*, Youfei Guan*, Guang Hui Liu*, Gang Pei*, Jian Li*, Yunfang Wang*
*Corresponding author for this work
  • CAS - Institute of Zoology
  • Chinese Academy of Sciences
  • Tsinghua University
  • CAS - Shanghai Institute of Nutrition and Health
  • CAS - Beijing Institute of Genomics
  • Central South University
  • Peking University
  • Shanghai University
  • Yiling Pharmaceutical Academician Workstation
  • Sichuan University
  • Xijing Hospital
  • Ministry of Education of the People's Republic of China
  • Tongji University
  • Fudan University
  • Third Military Medical University
  • Jinan University
  • Shanghai Jiao Tong University
  • Chongqing Medical University
  • Dalian Medical University
  • University of Chinese Academy of Sciences
  • Chinese Academy of Medical Sciences

Research output: Contribution to journalArticlepeer-review

Abstract

In human aging, liver aging per se not only increases susceptibility to liver diseases but also increases vulnerability of other organs given its central role in regulating metabolism. Total liver function tends to be well maintained in the healthy elderly, so liver aging is generally difficult to identify early. In response to this critical challenge, the Aging Biomarker Consortium of China has formulated an expert consensus on biomarkers of liver aging by synthesizing the latest scientific literature, comprising insights from both scientists and clinicians. This consensus provides a comprehensive assessment of biomarkers associated with liver aging and presents a systematic framework to characterize these into three dimensions: functional, imaging, and humoral. For the functional domain, we highlight biomarkers associated with cholesterol metabolism and liver-related coagulation function. For the imaging domain, we note that hepatic steatosis and liver blood flow can serve as measurable biomarkers for liver aging. Finally, in the humoral domain, we pinpoint hepatokines and enzymatic alterations worthy of attention. The aim of this expert consensus is to establish a foundation for assessing the extent of liver aging and identify early signs of liver aging-related diseases, thereby improving liver health and the healthy life expectancy of the elderly population.

Original languageEnglish
Article number004
JournalLife Medicine
Volume3
Issue number1
DOIs
StatePublished - 1 Feb 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement'. Together they form a unique fingerprint.

Cite this